BioSpace News Archive

Sin Hang Lee, MD, an internationally recognized Connecticut pathologist, in a letter yesterday to World Health Organization and White House Coronavirus Task Force representatives, offered to re-test borderline or questionable positive coronavirus samples that are growing in numbers, as testing nationwide increases

Medicago, a biopharmaceutical company headquartered in Quebec City, welcomes the support from the Government of Canada for the development of a vaccine against COVID-19.

Carnahan Group, a leading healthcare advisory firm, understands the amount of stress that the Coronavirus (Covid-19) pandemic places on healthcare providers.

The National Organization for Rare Disorders is pleased to welcome Prashant Goel as the new Vice President of Information Technology, based in the Danbury, CT office.

Tauriga Sciences Inc., (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has completed payment for the entirety of its initial production run of its Cannabigerol (“CBG”) infused version of Tauri-Gum™

New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument

Boston Engineering announced a reseller partnership to provide Ansys simulation engineering software and consulting throughout New England and the tri-state area.

The COVID-19 crisis has prompted an outpouring of support from the people of New Jersey.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the U.S. Food and Drug Administration has provided Emergency Use Authorization for the Company’s New Coronavirus RT-PCR test.

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced measures it is taking in response to the novel coronavirus pandemic (“COVID-19").